Publicacións en colaboración con investigadores/as de Charité (17)

2023

  1. Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries

    Annals of the rheumatic diseases, Vol. 82, Núm. 5, pp. 698-709

2022

  1. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry

    Annals of the rheumatic diseases, Vol. 81, Núm. 5, pp. 695-709

2020

  1. EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 7, pp. 851-858

  2. EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 11, pp. 1423-1431

2019

  1. EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases

    RMD Open, Vol. 5, Núm. 2

2018

  1. 2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis

    Annals of the Rheumatic Diseases, Vol. 77, Núm. 4, pp. 476-479

2017

  1. EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 4, pp. 639-646

  2. Economic considerations and patients' preferences affect treatment selection for patients with rheumatoid arthritis: A discrete choice experiment among European rheumatologists

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 126-132

  3. The 2017 EULAR standardised procedures for ultrasound imaging in rheumatology

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 12, pp. 1974-1979

  4. Transitional care for rheumatic conditions in Europe: Current clinical practice and available resources

    Pediatric Rheumatology, Vol. 15, Núm. 1

2016

  1. EULAR recommendations for the management of familial Mediterranean fever

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 4, pp. 644-651

  2. Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: A EULAR initiative

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 6, pp. 965-973

  3. Systematic review and critical appraisal of transitional care programmes in rheumatology

    Seminars in Arthritis and Rheumatism, Vol. 46, Núm. 3, pp. 372-379

2015

  1. The EULAR Study Group for Registers and Observational Drug Studies: Comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers

    Rheumatology (United Kingdom), Vol. 54, Núm. 6, pp. 1074-1079

2012

  1. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2197-2223

  2. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2163-2196

2010

  1. A Comparison of Patient Characteristics and Outcomes in Selected European and U.S. Rheumatoid Arthritis Registries1

    Seminars in Arthritis and Rheumatism, Vol. 40, Núm. 1, pp. 2-14.e1